Intestinal microbiota, bile acids activated receptors and metabolism: development of novel therapeutic targets in the treatment of steato-hepatitis (NASH) / Monti, M.C.. - (2019). (Intestinal microbiota, bile acids activated receptors and metabolism: development of novel therapeutic targets in the treatment of steato-hepatitis (NASH) 1 settembre 2019).
Intestinal microbiota, bile acids activated receptors and metabolism: development of novel therapeutic targets in the treatment of steato-hepatitis (NASH)
Maria Chiara Monti
2019
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


